Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$2.47M
610K shares
What this filing means
BORGESON BLAKE plans to sell 610K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $2.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001959173-26-001784
Director
Since Apr 2021
610K
Shares to sell
$2.47M
Approx. market value
170K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Founders Shares
Compensation
9/1/2017
60KFounders Shares
Compensation
9/1/2016
110KTotal acquired170K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2017 | Founders Shares Compensation | 60K | — |
9/1/2016 | Founders Shares Compensation | 110K | — |
| Total | 170K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
220K
Market value
$924.0K
2/3/2026
—Completed
Units to sell
220K
Market value
$959.2K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
170K
Market value
$588.2K
3/3/2026
Total
Units
610K
Value
$2.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 220K | $924.0K | — | Completed |
1/6/2026 | 220K | $959.2K | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 170K | $588.2K | NASDAQ | Planned |
| Total | 610K | $2.47M | ||